✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic GeneticsSubstance Use DisordersFamily HistoryPreventionRisk Assessment Why This MattersThis research illuminates how parental substance use...
Randomised Controlled Trial Evidence on Medicinal Cannabis for Treatment of Mental Health and Substance Use Disorders: A Scoping Review.
With shifting perceptions about the therapeutic potential of cannabis and evolving regulatory frameworks, global prescribing of medicinal cannabis is increas…
Endocannabinoid System Research: Cannabis for PTSD and SUD
Clinical Takeaway People with PTSD and co-occurring substance use disorders who use cannabis can still benefit meaningfully from trauma-focused treatments. Cannabis use does not appear to undermine the effectiveness of evidence-based PTSD...
`Cannabinoids for Mental & Substance Use Disorders: Evidence`
Clinical Takeaway Based on current randomized controlled trial evidence, the efficacy of cannabinoids for treating mental disorders and substance use disorders remains unestablished. Existing studies show limited and inconsistent benefits, and safety...
`Cannabinoid Clinical Trials for Mental & Substance Disorders`
Clinical Takeaway Systematic review and meta-analysis of randomized controlled trials found limited evidence supporting cannabinoids as a primary treatment for mental disorders or substance use disorders. Current data do not establish clear...
`Endocannabinoid System Research: Cannabis for PTSD & SUDs`
Clinical Takeaway People with PTSD and co-occurring substance use disorders who use cannabis show comparable outcomes to non-cannabis users when receiving trauma-focused treatment, suggesting cannabis use alone should not be a barrier...
`Cannabinoid Clinical Trials for Mental Health: Key Findings`
Clinical Takeaway Randomized controlled trial evidence on cannabinoids for mental health and substance use disorders remains limited and inconclusive, with neither clear efficacy nor a well-defined safety profile established across these conditions....
`Endocannabinoid System Research: Cannabis for PTSD and SUD`
Clinical Takeaway People with PTSD and co-occurring substance use disorders who also use cannabis can still benefit meaningfully from trauma-focused treatments. Clinicians should not withhold or delay evidence-based PTSD care solely because...
`Endocannabinoid System Research: Cannabis for PTSD & SUD`
Clinical Takeaway People with PTSD and co-occurring substance use disorders who use cannabis can still benefit meaningfully from trauma-focused treatments. Clinicians should not withhold or delay evidence-based PTSD care based on a...
`Cannabinoid Clinical Trials: PTSD and Substance Use`
Clinical Takeaway People with PTSD and co-occurring substance use disorders who use cannabis can still benefit meaningfully from trauma-focused treatments. Cannabis use does not appear to undermine the effectiveness of evidence-based PTSD...